Bishow C. Mahat (@bishow2337) 's Twitter Profile
Bishow C. Mahat

@bishow2337

Vascular and NIR Fellow @Pittstroke | Alum @PittNeurology @SXCMaitighar | Global Health, Football and @manutd

ID: 101209631

calendar_today02-01-2010 12:25:09

1,1K Tweet

530 Followers

475 Following

UPMC Neurology Residents (@upmcneuro) 's Twitter Profile Photo

Closing up the year, incredibly educative Grand Rounds by our blockbuster Academic Chief and incoming Stroke and Neuro-Endovascular fellow Bishow C. Mahat giving us invaluable insights into stroke care in resource limited settings learning from our residency Global Neurology Track

Closing up the year, incredibly educative Grand Rounds by our blockbuster Academic Chief and incoming Stroke and Neuro-Endovascular fellow <a href="/Bishow2337/">Bishow C. Mahat</a> giving us invaluable insights into stroke care in resource limited settings learning from our residency Global Neurology Track
Bishow C. Mahat (@bishow2337) 's Twitter Profile Photo

Can’t think of a better start to UPittStroke first day of Med cal! 30 calls, 4 TNK, 2 Thrombectomies. Can’t wait for the 2nd day!! #BlessedAndGrateful

Nirav Bhatt (@nirav_r_bhatt) 's Twitter Profile Photo

Excited to share our study showing acquisition of PSSS was associated with a significant reduction in Door-to-puncture (DTP) times among patients presenting directly to a thrombectomy center. jnis.bmj.com/content/early/… But what is a PSSS and why it may be important..

Eytan Raz (@eytanraz) 's Twitter Profile Photo

Thanks to the 150~ people who last week attended #BANANA2024 for three full intense days, coming from all over the world and from all specialties. See you in person at #BANANA2026 neuroangio.org

Thanks to the 150~ people who last week attended #BANANA2024 for three full intense days, coming from all over the world and from all specialties. See you in person at #BANANA2026 neuroangio.org
Giana Dawod, MD (@gdawod1) 's Twitter Profile Photo

#SVIN24 was a week ago, but the discussions regarding the latest in clinical trial updates are ongoing! Check out these tables that Mica Schachter, MD 🇺🇲🇦🇷 & I put together to summarize the exciting new studies currently in the works to move us #ForwardTogether ⏩🧠💉🩸 SVIN

#SVIN24 was a week ago, but the discussions regarding the latest in clinical trial updates are ongoing! 

Check out these tables that <a href="/neurona_critica/">Mica Schachter, MD 🇺🇲🇦🇷</a> &amp; I put together to summarize the exciting new studies currently in the works to move us #ForwardTogether ⏩🧠💉🩸

<a href="/svinsociety/">SVIN</a>
Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile Photo

Grateful to the patients, families, and investigators who contributed to VERITAS. Efficacy at extremes of severity (NIHSS<9; pc-ASPECTS 0-5) remains uncertain, but MT benefits a broad range of VBAO patients within 24h, regardless of age, IVT use, etiology, or occlusion level.

Grateful to the patients, families, and investigators who contributed to VERITAS. Efficacy at extremes of severity (NIHSS&lt;9; pc-ASPECTS 0-5) remains uncertain, but MT benefits a broad range of VBAO patients within 24h, regardless of age, IVT use, etiology, or occlusion level.
Mohamed F Doheim, MD (@fahmy_doheim) 's Twitter Profile Photo

Excited to share new insights from the POSITIVE study on long-term outcomes of IV Tirofiban+EVT in posterior circulation tandem lesions at #ISC2025 AmericanHeartAssocMN Stroke AHA/ASA! Can’t be more grateful to my mentor Raul G Nogueira, MD, FAHA, FSVIN, my collaborators and our team UPittStroke!

Excited to share new insights from the POSITIVE study on long-term outcomes of IV Tirofiban+EVT in posterior circulation tandem lesions at #ISC2025 <a href="/HeartAssocMN/">AmericanHeartAssocMN</a> <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a>! 

Can’t be more grateful to my mentor <a href="/RaulNogueiraMD/">Raul G Nogueira, MD, FAHA, FSVIN</a>, my collaborators and our team <a href="/PittStroke/">UPittStroke</a>!
Bishow C. Mahat (@bishow2337) 's Twitter Profile Photo

This might be the end of Dalot. He has been nowhere near his prior level. The number if time he wastes the attacking chances is crazy! #MUNIPS